Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2017
Mar. 31, 2017
Current assets    
Cash $ 5,610,799 $ 1,559,701
Prepaid expenses and other current assets 14,537 37,551
Total current assets 5,625,336 1,597,252
Property and equipment, net 32,398 29,223
Patents and patents pending, net 78,123 84,996
Deposits 14,897 14,897
Total assets 5,750,754 1,726,368
Current liabilties    
Accounts payable 211,406 484,423
Due to related parties 64,466 57,866
Other current liabilities 60,534 69,467
Total current liabilities 336,406 611,756
Convertible notes payable, net 810,866 519,200
Total liabilities 1,147,272 1,130,956
Stockholders' Equity    
Common stock, par value $0.001 per share; 30,000,000 shares authorized as of December 31, 2017 and March 31, 2017; 15,367,658 and 8,797,086 shares issued and outstanding as of December 31, 2017 and March 31, 2017, respectivelyCommon stock, par value $0.001 per share; 30,000,000 shares authorized as of December 31, 2017 and March 31, 2017; 15,367,658 and 8,797,086 shares issued and outstanding as of December 31, 2017 and March 31, 2017, respectively 15,368 8,796
Additional paid-in capital 102,820,906 94,445,739
Accumulated deficit (98,138,853) (93,778,156)
Total Aethlon Medical, Inc. stockholders' equity before noncontrolling interests 4,697,421 676,379
Noncontrolling interests (93,939) (80,967)
Total stockholders' equity 4,603,482 595,412
Total liabilities and stockholders' equity $ 5,750,754 $ 1,726,368